Full Prescribing Information
Patient Information
Healthcare Professional Site
BMS Access Support®
Indication
What is ONUREG?
ONUREG (azacitidine) is an oral prescription medicine used to treat adults with acute myeloid leukemia (AML) who are in first complete remission (CR) (with or without recovery of your blood cell counts) after intensive induction chemotherapy and are not able to complete intensive curative therapy.
It is not known if ONUREG is safe and effective in children under 18 years of age.
What is AML remission and why is it important?
Treating your AML after remission
Making treatment decisions that are right for you
Why ONUREG?
Possible side effects of ONUREG
Managing side effects of ONUREG
How to take ONUREG
Checklist for taking ONUREG
Your role as a caregiver
Working with your loved one's healthcare team
Caring for yourself
ONUREG patient stories
Frequently asked questions about ONUREG
Helpful resources
Page Not Found
The requested page could not be found. Please return to the home page or view the site map.
